The preceding analysis suggests a transcriptomic pattern downstream of FAM3C/LIFR/STAT3 modulation that is specifically implicated in mammary carcinoma pathology and that is exemplified by changes in the regulation of an established mediator of EMT and cell fate, TWIST1. The gene discussed is TWIST1; the disease is breast carcinoma.